266 results on '"Wrammert, Jens"'
Search Results
2. Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies
3. Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study
4. Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
5. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
6. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
7. Altered amino acid profile in patients with SARS-CoV-2 infection
8. Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
9. Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal Cohort Study
10. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
11. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers
12. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells
13. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
14. 1103. Endemic Coronavirus Infections in a US Cohort of Children from Birth to 4 Years
15. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood
16. The amphibian peptide Yodha is virucidal for Zika and dengue viruses
17. Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron
18. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans
19. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
20. Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
21. Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
22. Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
23. Development of a Monoclonal Antibody to a Vibriophage as a Proxy for Vibrio cholerae Detection
24. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
25. BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data
26. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
27. Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.
28. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
29. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
30. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
31. Application of SARS-CoV-2 Serology to Address Public Health Priorities
32. Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine
33. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
34. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
35. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)
36. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
37. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
38. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
39. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties ofVibrio choleraeO-Specific Polysaccharide-Specific Monoclonal Antibodies
40. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
41. Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19
42. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility
43. Editorial: Advances in Plasma Cells in Health and Disease
44. COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease
45. Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
46. Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine
47. Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding
48. Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease
49. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
50. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.